Given its broad readership and focus on practical medical science, the journal is also a suitable venue for discussions of essential medicines such as mebendazole. Research or case-based reporting on this antiparasitic treatment can be especially relevant in settings where intestinal helminth infections remain a public health concern. Such work may address diagnosis, treatment access, dosing practices, resistance concerns, or community-based deworming strategies. In this way, a topic like mebendazole fits naturally within the journal’s wider mission to support evidence-based care, medical education, and health policy.